← All organizations
Highest phase reached
Phase 4
First clinical trial
Feb 1, 2014Last known activity
Sep 23, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (3 distinct, 7 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Indications
Recent trials (13)
- NCT07187804Lead sponsorPhase 4Sep 23, 2025
- NCT07187804Sponsor investigatorPhase 4Sep 23, 2025
- NCT06683950Lead sponsorPhase 4Oct 21, 2024
- NCT06683950Sponsor investigatorPhase 4Oct 21, 2024
- NCT06487039OfficialPhase 2Aug 1, 2024
- NCT05662410Lead sponsorPhase 4Dec 26, 2022
- NCT05662410Reponsible party - principal investigatorPhase 4Dec 26, 2022
- NCT05662410Sponsor investigatorPhase 4Dec 26, 2022
- NCT04655482Lead sponsorPhase 4Dec 20, 2020
- NCT04655482Overall official - principal investigatorPhase 4Dec 20, 2020
- NCT03169660Overall official - principal investigatorPhase 4Dec 1, 2015
- NCT03169660Lead sponsorPhase 4Dec 1, 2015
- NCT02072408CollaboratorPhase 4Feb 1, 2014
Details
- Last known activity
- Sep 23, 2025